volume 54, issue 1, P81-83 2010
DOI: 10.1590/s0004-27302010000100014
View full text
|
Sign up to set email alerts
|
Share

Abstract: To the Editor, We have read with great interest the recent article by Rollin and collaborators (1) concerning the use of glargine and NPH insulin in children (0-8 years old) with type 1 diabetes mellitus (T1DM). We would like to comment on the context which it emerges from, on aspects about the study design, and on how data is presented and interpreted. We believe that taking our comments into account would substantially change the interpretation drawn from this study.Glargine is an insulin analog that, in th…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals